Adults with prediabetes experience a faster decline in kidney function than those with normal glucose, highlighting the need ...
The benefits of SGLT2 inhibitors on kidney disease progression in individuals irrespective of diabetes or albuminuria status ...
Targeted cancer therapies like CDK4/6, EGFR, VEGFR, and BRAF inhibitors may increase long-term kidney dysfunction risk. Learn ...
Nearly all adults with chronic kidney disease would benefit from a systolic blood pressure target of less than 120 versus less than 140 mm Hg.